Mammalian cells that express VEGF-D polypeptides

Details Mammalian cells that express VEGF-D polypeptides Mammalian cells that express VEGF-D polypeptides

2011-01-18

2011-01-18

Saoud, Christine J (Department: 1647)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

C435S320100, C435S325000, C435S366000, C435S369000, C536S023500

Reexamination Certificate

active

07871798

ABSTRACT:
Disclosed herein are mammalian cells transformed or transfected with a VEGF-D nucleic acid consisting of a nucleotide sequence encoding continuous portions of VEGF-D polypeptides.

REFERENCES:
patent: 5194596 (1993-03-01), Tischer et al.
patent: 5968778 (1999-10-01), Hoppe et al.
patent: 6221839 (2001-04-01), Alitalo et al.
patent: 6235713 (2001-05-01), Achen et al.
patent: 6383484 (2002-05-01), Achen et al.
patent: 6689580 (2004-02-01), Achen et al.
patent: 6828426 (2004-12-01), Hirata et al.
patent: 7122654 (2006-10-01), Achen et al.
patent: 2002/0123481 (2002-09-01), Oliviero
patent: 2003/0125537 (2003-07-01), Achen et al.
patent: 2003/0166547 (2003-09-01), Oliviero
patent: 2006/0177428 (2006-08-01), Achen et al.
patent: 0 539 748 (1993-05-01), None
patent: 0 578 909 (1994-01-01), None
patent: 9519928.7 (1995-09-01), None
patent: 9612368.2 (1996-06-01), None
patent: 0935001 (1999-08-01), None
patent: 1 283 268 (2003-02-01), None
patent: 0 956 339 (2005-10-01), None
patent: 8-185216 (1996-07-01), None
patent: WO-94/02511 (1994-02-01), None
patent: WO-95/24473 (1995-09-01), None
patent: WO-96/11269 (1996-04-01), None
patent: WO-96/26736 (1996-09-01), None
patent: WO-96/27007 (1996-09-01), None
patent: WO-96/39421 (1996-12-01), None
patent: WO-97/05250 (1997-02-01), None
patent: WO-97/12972 (1997-04-01), None
patent: WO-98/02543 (1998-01-01), None
patent: WO-98/07832 (1998-02-01), None
patent: WO-98/24811 (1998-06-01), None
U.S. Appl. No. 11/692,774, Achen et al.
U.S. Appl. No. 11/692,753, Achen et al.
Achen et al., “The Non-receptor Tyrosine Kinase Lyn is Localised in the Developing Murine Blood-brain Barrier,”Differentiation, 59:15-24 (1995).
Andersson et al., “Involvement of Loop 2 of Platelet-derived Growth Factor-AA and -BB in Receptor Binding,”Growth Factors, 12:159-164 (1995).
Andersson et al., “Assignment of Interchain Disulfide Bonds in Platelet-derived Growth Factor (PDGF) and Evidence for Agonist Activity of Monomeric PDGF,”J. Biol. Chem., 267:11260-11266 (1992).
Aruffo et al., “Molecular Cloning of a CD28 cDNA by a High-efficiency COS Cell Expression System,”PNAS, 84:8573-8577 (1987).
Cao et al., “gro-β, a -C-X-C- Chemokine, is an Angiogenesis Inhibitor that Suppresses the Growth of Lewis Lung Carcinoma in Mice,”J. Exp. Med., 182:2069-2077 (1995).
Claffey et al., “Structural Requirements for Dimerization, Glycosylation, Secretion, and Biological Function of VPF/VEGF,”Biochim. Biophys. Acta., 1246:1-9 (1995).
Dignam et al., “Balbiani Ring 3 inChironomus tentansEncodes a 185-kDa Secretory Protein which is Synthesized Throughout the Fourth Larval Instar,”Gene, 88:133-140 (1990).
Ferrara et al., “The Vascular Endothelial Growth Factor Family of Polypeptides,”J. Cell. Biochem., 47:211-218 (1991).
Flemming et al., “Reversion of Autocrine Transformation by a Dominant Negative Platelet-Derived Growth Factor Mutant,”Mol. Cell Biol., 13:4066-4076 (1993).
Folkman et al., “Angiogenesis,”J. Biol. Chem., 267:10931-10934 (1992).
Gospodarowicz et al., “Isolation and Characterization of a Vascular Endothelial Cell Mitogen Produced by Pituitary-derived Folliculo Stellate Cells,”PNAS, 86:7311-7315 (1989).
Haefliger et al., “Four Novel Members of the Connexin Family of Gap Junction Proteins,”J. Biol. Chem., 267:2057-2064 (1992).
Hatva et al., “Vascular Growth Factors and Receptors in Capillary Hemangioblastomas and Hemangiopericytomas,”Am. J. Pathol., 148(3):763-775 (1996).
Hillier et al., GenBank Accession No. H24828 (1995).
Holloway et al., “Chromosomal Mapping of Five Highly Conserved Murine Homologues of theDrosophilaRING Finger GeneSeven-in-absentia,” Genomics, 41:160-168 (1997).
Houck et al., “Dual Regulation of Vascular Endothelial Growth Factor Bioavailability by Genetic and Proteolytic Mechanisms,”J. Biol. Chem., 267(36):26031-26037 (1992).
Jenkins et al., “Organization, Distribution, and Stability of Endogenous Ecotropic Murine Leukemia Virus DNA Sequences in Chromosomes ofMus musculus,” J. Virol., 43:26-36 (1992).
Joukov et al., “A Novel Vascular Endothelial Growth Factor, VEGF-C, is a Ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) Receptor Tyrosine Kinases,”EMBO J., 15:290-298 (1996).
Kaipainen et al., “Enhanced Expression of the Tie Receptor Tyrosine Kinase Messenger RNA in the Vascular Endothelium of Metastatic Melanomas,”Cancer Res., 54:6571-6577 (1994).
Kaipainen et al., “Expression of the Fms-like Tyrosine Kinase 4 Gene Becomes Restricted to Lymphatic Endothelium During Development,”PNAS, 92:3566-3570 (1995).
Kim et al., “The Vascular Endothelial Growth Factor Proteins: Identification of Biologically Relevant Regions by Neutralizing Monoclonal Antibodies,”Growth Factors, 7:53-64 (1992).
Leung et al., “Vascular Endothelial Growth Factor is a Secreted Angiogenic Mitogen,”Science, 246:1306-1309 (1989).
Montesano et al., “Basic Fibroblast Growth Factor Induces Angiogenesis in Vitro,”PNAS, 83:7297-7301 (1986).
Oefner et al., “Crystal Structure of Human Platelet-derived Growth Factor BB,”EMBO J., 11:3931-3926 (1992).
Oelrichs et al., “NYK/FLK-1: A Putative Receptor Protein Tyrosine Kinase Isolated from E10 Embryonic Neuroepithelium is Expressed in Endothelial Cells of the Developing Embryo,”Oncogene, 8:11-18 (1993).
Ostman et al., “Identification of Three Amino Acids is the Platelet-derived Growth Factor (PDGF) B-chain that are Important for Binding to the PDGF β-Receptor,”J. Biol. Chem., 266:10073-10077 (1991).
Olofsson et al., “Vascular Endothelial Growth Factor B, a Novel Growth Factor for Endothelial Cells”PNAS, 93:2576-2581 (1996).
Orlandini et al., “Identification of ac-fos-induced Gene that is Related to teh Platelet-derived Growth Factor/Vascular Endothelial Growth Factor Family,”PNAS, 93:11675-11680 (1996).
Patil et al., “DNA-based Therapeutics and DNA Delivery Systems: A Comprehensive Review,”AAPS Journal, 17:E61-E77 (2005).
Paulsson et al., “The Balbiani Ring 3 Gene inChironomus tentanshas a Diverged Repetitive Structure Split by Many Introns,”J. Mol. Biol., 211:331-349 (1990).
Plate et al., “Angiogenesis in Malignant Gliomas,”GLIA, 15(3):339-347 (1995).
Potgens et al., “Covalent Dimerization of Vascular Permeability Factor/Vascular Endothelial Growth Factor is Essential for its Biological Activity,”J. Biol. Chem., 269:32879-32885 (1994).
Rastinejad et al., “Regulation of the Activity of a New Inhibitor of Angiogenesis by a Cancer Suppressor Gene,”Cell, 56:345-355 (1989).
Sambrook et al.,Molecular Cloning: A Laboratory Manual, 2nd Ed, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York(1989).
Sanger et al., “DNA Sequencing with Chain-terminating Inhibitors,”PNAS, 74:5463-5467 (1977).
Stacker et al., “Biosynthesis of Vascular Endothelial Growth Factor-D Involves Proteolytic Processing which Generates Non-covalent Homodimers,”J. Biol. Chem., 274(45):32127-32136 (1999).
Strawn et al., “Flk-1 as a Target for Tumor Growth Inhibition,”Cancer Res., 56:3540-3545 (1996).
Tischer et al., “Vascular Endothelial Growth Factor: A New Member of the Platelet-derived Growth Factor Gene Family,”Biochem. Biophys. Res. Comm., 163:1198-1206 (1989).
Yamada et al., “Molecular Cloning of a Novel Vascular Endothelial Growth Factor, VEGF-D,”Genomics, 42:483-488 (1997).
European Search Report from the European Patent Office, dated Jul. 17, 2007.
Notice to Declare Interference dated Aug. 26, 2009, Interference No. 105,695, Achen (U.S. Appl. No. 11/304,585) and Hirata (U.S. Appl. No. 11/397,289).
Interference Initial Memorandum, Interference No. 105,695 dated May 21, 2009, Achen (U.S. Appl. No. 11/304,585) and Hirata (U.S. Appl. No. 11/397,289).
Notice to Declare

Affiliated with

Also associated with

Rating

Mammalian cells that express VEGF-D polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mammalian cells that express VEGF-D polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mammalian cells that express VEGF-D polypeptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2724136